tru Independence’s Myovant Sciences Ltd. MYOV Stock Holding History

tru Independence’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-700	Closed	-$19.3K	–	754
2020 Q4	$19.3K	Buy	+700	New	+$13.6K	0.04%	193

Other funds holding MYOV

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return

tru Independence's MYOV Position: Q1 2021 in Review

tru Independence sold out of Myovant Sciences Ltd. (MYOV) in Q1 2021, closing a stake of 700 shares — an estimated $19.3K sold.

tru Independence first reported a position in MYOV in Q4 2020 and held it in 1 quarter. The position peaked at $19.3K in Q4 2020. 104 funds tracked by Wall St. Rank hold MYOV as of Q1 2021.

tru Independence reported no remaining Myovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
tru Independence sold 700 Myovant Sciences Ltd. shares in Q1 2021, an estimated $19.3K.
tru Independence first reported a position in Myovant Sciences Ltd. in Q4 2020 and held it in 1 quarter.
tru Independence's Myovant Sciences Ltd. position peaked at $19.3K in Q4 2020.
104 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2021.

Based on tru Independence's 13F filing for Q1 2021, filed 20 May 2021.